Grants and Contracts Details
Description
Allogeneic hematopoietic cell transplantation (allo-HCT) often presents the only chance
for cure in patients with hematological malignancies. Its benefits are counteracted by the
development of Graft versus-host disease (GVHD). It more and more becomes clear, that effector
cells of both adaptive and innate immunity contribute. The pro-inflammatory role of recipient
neutrophils in the early pathogenesis ofGVHD was recently demonstrated by our group (Nature
Medicine 2014: 20,648-654), while the role of donor neutrophils later in the course of disease is
poorly understood. Preliminary data from our lab shows that neutrophil depletion during the time
of donor cell recovery reduces gastrointestinal GVHD and possibly improves overall outcome.
Lethally irradiated B6D2F1 mice received hematopoietic cells from allo C57BL/6 or syngeneic
B6D2F1 donors. While significant mortality by week 6 was observed in allo controls (40%), all
recipients receiving Ly-6G Ab survived. Interestingly, in addition to decreased pathology in the
colon, bronchoalveolar lavage fluid cellularity was decreased as surrogate marker for reduced lung
inflammation. Our Kentucky patient population is prone to increased risk for lung toxicity and
pulmonary GVHD, as life style habits, such as smoking, and associated impaired lung function
renders Kentucky transplant patients especially vulnerable. We aim to better identify the role of
neutrophils in pulmonary GVHD. Chemokine receptor CXCR2 is a receptor expressed on
neutrophils and critical for neutrophil migration. It has been shown to be involved in non-transplant
neutrophil-mediated lung injury. Using different methods of neutrophils depletion (anti-Ly6G
neutrophil depleting antibody) or targeting CXCR2 (CXCR2 deficient donors, SB225002 selective
non-peptide inhibitor of CXCR2, anti-CXCR2 MAB 2164 antibody (R&DSystems)) we will
characterize the role of neutrophil influx into the lung after transplant. This work will be a direct
extension of our prior work identifying several signaling pathways involved in T cell and
monocyte/macrophage migration to the lung.
Status | Finished |
---|---|
Effective start/end date | 7/1/17 → 6/30/18 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.